184 related articles for article (PubMed ID: 32662534)
1. Rituximab in treatment of collapsing FSGS-A case series.
Girimaji N; Bharati J; Nada R; Rathi M; Kohli HS; Ramachandran R
Nephrology (Carlton); 2021 Feb; 26(2):134-141. PubMed ID: 32662534
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis.
Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Suzuki Y; Ohara S; Hosoya M
Pediatr Int; 2016 Mar; 58(3):219-223. PubMed ID: 26275234
[TBL] [Abstract][Full Text] [Related]
5. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
Garrouste C; Canaud G; Büchler M; Rivalan J; Colosio C; Martinez F; Aniort J; Dudreuilh C; Pereira B; Caillard S; Philipponnet C; Anglicheau D; Heng AE
Transplantation; 2017 Mar; 101(3):649-656. PubMed ID: 27043407
[TBL] [Abstract][Full Text] [Related]
7. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
8. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
Tatangelo P; Londrino F; Di Vasta G; Guido G; Centi A; Dominijanni S; Bernabei E; Caramiello MS; Di Franco D; Palumbo R
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786187
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Different Immunosuppressive Regimen in Adult Biopsy Proven Idiopathic Focal Segmental Glomerulosclerosis: A Retrospective Analysis at a Single Center.
Qureshi R; Nasir K; Imtiaz S; Dhrolia MF; Ahmad A; Salman B
Saudi J Kidney Dis Transpl; 2022; 33(1):111-121. PubMed ID: 36647985
[TBL] [Abstract][Full Text] [Related]
10. Treatment of steroid-resistant focal segmental glomerulosclerosis with rituximab: A case report and review of literature.
Varwani MH; Sokwala A
Saudi J Kidney Dis Transpl; 2017; 28(5):1175-1179. PubMed ID: 28937082
[TBL] [Abstract][Full Text] [Related]
11. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis.
Chang JW; Yang LY; Wang HH
Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834
[TBL] [Abstract][Full Text] [Related]
12. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in maintaining remission in adults with podocytopathy.
Ramachandran R; Bharati J; Nada R; Minz R; Kohli HS
Nephrology (Carlton); 2020 Aug; 25(8):616-624. PubMed ID: 32297386
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
Wee Leng G; Mustafar R; Kamaruzaman L; Mohd R; Cader RA; Wei Yen K; Kiew Bing P
Acta Med Indones; 2018 Jul; 50(3):237-243. PubMed ID: 30333274
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
[TBL] [Abstract][Full Text] [Related]
16. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
Soyaltın E; Demir BK; Alparslan C; Çamlar SA; Alaygut D; Yavaşcan Ö; Mutlubaş F
Turk J Pediatr; 2020; 62(4):663-667. PubMed ID: 32779421
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L; Lin Y; Yu B; Wang Y; Pan H; Wang H; Lou X; Lang X; Zhang Q; Jin L; Yang Y; Xiao L; Chen J; Han F
Am J Nephrol; 2024; 55(1):25-36. PubMed ID: 37963441
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic collapsing glomerulopathy in children.
Gulati A; Sharma A; Hari P; Dinda AK; Bagga A
Clin Exp Nephrol; 2008 Oct; 12(5):348-353. PubMed ID: 18392736
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.
Kaito H; Kamei K; Kikuchi E; Ogura M; Matsuoka K; Nagata M; Iijima K; Ito S
Pediatr Nephrol; 2010 May; 25(5):957-9. PubMed ID: 20033219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]